12/16/2024
6:07 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:08 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/27/2024
7:43 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
7:45 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:41 PM | KalVista Pharmaceuticals (Issuer)
Reid Laurence (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/26/2024
6:06 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
6:18 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:18 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:19 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
11:54 AM | Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
1:34 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/04/2024
3:40 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
11:00 AM | KalVista Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:00 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:05 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:06 PM | KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:07 PM | KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:08 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
3:34 PM | KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
7:31 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:39 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:24 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:07 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/26/2024
6:58 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
7:00 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:13 PM | KalVista Pharmaceuticals (Filer)
| Form DEFA14A | |
08/22/2024
3:17 PM | KalVista Pharmaceuticals (Filer)
| Form ARS | |
08/22/2024
3:08 PM | KalVista Pharmaceuticals (Filer)
| Form DEF 14A | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:25 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
8:26 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:23 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | KalVista Pharmaceuticals (Filer)
| Form EFFECT | |
07/11/2024
3:49 PM | KalVista Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
3:21 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
06/10/2024
5:42 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:55 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:57 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:58 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:59 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:34 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2024
3:35 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:37 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:50 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:38 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:35 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
02/22/2024
12:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/21/2024
8:51 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:41 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:44 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:46 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:48 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:49 PM | KalVista Pharmaceuticals (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13D/A | |
02/16/2024
3:32 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:21 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:52 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
4:13 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
02/13/2024
8:11 AM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:20 AM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:23 AM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:06 AM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:08 AM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:55 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:30 PM | KalVista Pharmaceuticals (Subject)
Saturn V Capital Management LP (Filed by)
| Form SC 13G | |
02/09/2024
8:16 AM | KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
7:11 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:38 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:07 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
7:24 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:02 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:04 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:26 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:57 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
5:05 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:24 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
3:47 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:13 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:44 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:16 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023
4:12 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
